Search research articles
Contact Us
Filters
Showing results (1-10 of 15) with videos related to
Page
of 2
Sort By:
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
October 17, 2025
Elecsys CSF AD immunoassays: Sample stability for a new pre-analytical protocol for fresh CSF
Ekaterina Manuilova, Isabelle Schrurs, Sandra Rutz, et al.
Clinical Chemistry and Laboratory Medicine
|
November 19, 2013
NGAL, L-FABP, and KIM-1 in comparison to established markers of renal dysfunction
Leon Holzscheiter, Claus Beck, Sandra Rutz, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
September 23, 2022
Clinical performance and robustness evaluation of plasma amyloid-β<sub>42/40</sub> prescreening
Christina Rabe, Tobias Bittner, Alexander Jethwa, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)
|
December 23, 2020
Pre-analytical protocol for measuring Alzheimer's disease biomarkers in fresh CSF
Oskar Hansson, Sandra Rutz, Henrik Zetterberg, et al.
Plos One
|
December 17, 2015
Comparison of Plasma and Urine Biomarker Performance in Acute Kidney Injury
Gunnar Schley, Carmen Köberle, Ekaterina Manuilova, et al.
Clinical Chemistry and Laboratory Medicine
|
October 25, 2022
Second-generation Elecsys cerebrospinal fluid immunoassays aid diagnosis of early Alzheimer's disease
Kaj Blennow, Erik Stomrud, Henrik Zetterberg, et al.
Clinical Biochemistry
|
May 27, 2019
Method comparison study of the Elecsys® β-Amyloid (1-42) CSF assay versus comparator assays and LC-MS/MS
Leslie M Shaw, Oskar Hansson, Ekaterina Manuilova, et al.
Clinical Chemistry and Laboratory Medicine
|
March 11, 2025
Concordance between the updated Elecsys cerebrospinal fluid immunoassays and amyloid positron emission tomography for Alzheimer's disease assessment: findings from the Apollo study
Henrik Schinke, Magnus Förnvik Jonsson, Mayme Gummesson, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
October 14, 2025
Blood-based pre-screening in the SKYLINE secondary prevention Ph3 gantenerumab study
Alina Bauer, Christina Rabe, Courtney Schiffman, et al.
Alzheimer'S Research & Therapy
|
April 3, 2020
Elecsys CSF biomarker immunoassays demonstrate concordance with amyloid-PET imaging
James D Doecke, Larry Ward, Samantha C Burnham, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 15) with videos related to
Sort By:
Page
of 2
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
October 17, 2025
Elecsys CSF AD immunoassays: Sample stability for a new pre-analytical protocol for fresh CSF
Ekaterina Manuilova, Isabelle Schrurs, Sandra Rutz, et al.
Clinical Chemistry and Laboratory Medicine
|
November 19, 2013
NGAL, L-FABP, and KIM-1 in comparison to established markers of renal dysfunction
Leon Holzscheiter, Claus Beck, Sandra Rutz, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
September 23, 2022
Clinical performance and robustness evaluation of plasma amyloid-β<sub>42/40</sub> prescreening
Christina Rabe, Tobias Bittner, Alexander Jethwa, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)
|
December 23, 2020
Pre-analytical protocol for measuring Alzheimer's disease biomarkers in fresh CSF
Oskar Hansson, Sandra Rutz, Henrik Zetterberg, et al.
Plos One
|
December 17, 2015
Comparison of Plasma and Urine Biomarker Performance in Acute Kidney Injury
Gunnar Schley, Carmen Köberle, Ekaterina Manuilova, et al.
Clinical Chemistry and Laboratory Medicine
|
October 25, 2022
Second-generation Elecsys cerebrospinal fluid immunoassays aid diagnosis of early Alzheimer's disease
Kaj Blennow, Erik Stomrud, Henrik Zetterberg, et al.
Clinical Biochemistry
|
May 27, 2019
Method comparison study of the Elecsys® β-Amyloid (1-42) CSF assay versus comparator assays and LC-MS/MS
Leslie M Shaw, Oskar Hansson, Ekaterina Manuilova, et al.
Clinical Chemistry and Laboratory Medicine
|
March 11, 2025
Concordance between the updated Elecsys cerebrospinal fluid immunoassays and amyloid positron emission tomography for Alzheimer's disease assessment: findings from the Apollo study
Henrik Schinke, Magnus Förnvik Jonsson, Mayme Gummesson, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
October 14, 2025
Blood-based pre-screening in the SKYLINE secondary prevention Ph3 gantenerumab study
Alina Bauer, Christina Rabe, Courtney Schiffman, et al.
Alzheimer'S Research & Therapy
|
April 3, 2020
Elecsys CSF biomarker immunoassays demonstrate concordance with amyloid-PET imaging
James D Doecke, Larry Ward, Samantha C Burnham, et al.
Page
of 2